XNAS · DCOY
-2.44% · -$0.0800 · Vol 15.2K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$3.20
Card
Relationship Map

Veridion Score

BETALOW CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
DCOY
Decoy Therapeutics Inc. Common Stock
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

53/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is DCOY moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading DCOY catalysts
About Decoy Therapeutics Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2015
Employees
11
Country
US

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$3.30
Day high
$3.43
Day low
$3.17
Previous close
$3.28
52W high
$15.00
-78.67% from high
52W low
$3.17
0% of range
Market cap
$2.1M
EPS
$-17.2800
Beta
2.23
Shares out
655.2K
Volume
15.2K
0.24× rel vol
Avg volume
63.4K
VWAP
$3.27
Price history computed in-house
1W
-9.09%
1M
-36.51%
3M
-58.06%
SMA 50 $5.21 · below
SMA 200 Not reported · Not reported
52W position 0%

DCOY overview

Veridion Score
53
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around DCOY.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading DCOY Form 4 filings
Public disclosures

Congress activity in DCOY

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for DCOY in the cached public ledger.

Federal contracts

DCOY contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for DCOY in this window.
Lobbying spend

DCOY lobbying filings, year to date.

Registered lobbying filings matched to Decoy Therapeutics Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for DCOY in this window.
Loading news for DCOY
Analyst ratings
Sovereign unlock shows live analyst consensus for DCOY.
Options
Sovereign unlock shows live options positioning for DCOY.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.